About CURC

This author has not yet filled in any details.
So far CURC has created 200 blog entries.

Dr. Shore’s article chosen as a NEJM “Most Notable Articles of 2020”

Neal Shore, MD, Article Featured in Notable Articles of 2020 by The New England Journal of Medicine. The New England Journal of Medicine editors have selected Dr. Shore's article Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer to be featured in Notable Articles of 2020. This is a selection of articles that have been the most [...]

By | January 13th, 2021|

Prospective evaluation of fexapotide triflutate injection treatment of Grade Group 1 prostate cancer: 4-year results

Neal Shore, Steven A. Kaplan, Ronald Tutrone, Richard Levin, James Bailen, Alan Hay, Susan Kalota, Mohamed Bidair, Sheldon Freedman, Kenneth Goldberg, Frederick Snoy & Jonathan I. Epstein Click here to read more.

By | December 7th, 2020|

Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial

Prof Stephen A Boorjian, MD, Mehrdad Alemozaffar, MD, Prof Badrinath R Konety, MD, Neal D Shore, MD, Prof Leonard G Gomella, MD, Prof Ashish M Kamat, MD, et al. Background: BCG is the most effective therapy for high-risk non-muscle-invasive bladder cancer. Nadofaragene firadenovec (also known as rAd-IFNa/Syn3) is a replication-deficient recombinant adenovirus that delivers human interferon [...]

By | December 1st, 2020|

Resetting the Bar of Castration Resistance – Understanding Androgen Dynamics in Therapy Resistance and Treatment Choice in Prostate Cancer

Neal D. Shore, Alicia K. Morgans, Charles J. Ryan Click here to read more.

By | November 4th, 2020|

Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer

Maha Hussain, M.D., Joaquin Mateo, M.D., Karim Fizazi, M.D., Fred Saad, M.D., Neal Shore, M.D., Shahneen Sandhu, M.D., Kim N. Chi, M.D., Oliver Sartor, M.D., Neeraj Agarwal, M.D., David Olmos, M.D., Antoine Thiery-Vuillemin, M.D., Przemyslaw Twardowski, M.D., et al., for the PROfound Trial Investigators* Click here to read more.

By | September 21st, 2020|

Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide

Karim Fizazi, M.D., Neal Shore, M.D., Teuvo L. Tammela, M.D., Ph.D., Albertas Ulys, M.D., Egils Vjaters, M.D., Sergey Polyakov, M.D., Mindaugas Jievaltas, M.D., Murilo Luz, M.D., Boris Alekseev, M.D., Iris Kuss, M.D., Marie-Aude Le Berre, M.Sc., Oana Petrenciuc, M.D., et al., for the ARAMIS Investigators* Click here to read more.

By | September 11th, 2020|